Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Fox Communications

- PMLiVE

UK study supports earlier narcolepsy finding with GSK’s Pandemrix

Flu vaccine linked to sleeping disorder

- PMLiVE

CHMP upholds rejection of Vivus’ obesity drug

Still no recommendation for Qsiva in Europe

- PMLiVE

WHO says people now expect universal health coverage

But director general says nations need to take own path to achieve this goal

- PMLiVE

Global counterfeit drug business driven by crime and corruption

Institute of Medicines says international cooperation needed to tackle falsified medicines

- PMLiVE

GSK signs obesity research deal with Vanderbilt University

Follows increased push from pharma to tackle the public health challenge

- PMLiVE

WHO appoints regional director for the Americas

Dominica’s Dr Carissa Etienne has rich history in healthcare policy

- PMLiVE

New US Coca-Cola ad while Russia tightens food legislation

Soft drinks giant launches low-cal ad in US while Russia plans tough legislation on fast food advertising and labelling, as pressure on fast food companies grows

- PMLiVE

Takeda ends obesity alliance with Amylin

Comes more than a year after development of lead product was pulled

- PMLiVE

England’s chief medical officer warns of rising liver disease rates

First annual report also provides data to help improve public health efforts in the country

- PMLiVE

Access to AIDS treatment up by two thirds as countries increase investment

UNAIDS report says 8 million people in developing nations are now receiving antiretroviral therapy

- PMLiVE

ECDC appoints France’s Françoise Weber as chair

Tiiu Aro of Estonia elected deputy chair of the European Centre for Disease Prevention and Control

- PMLiVE

Vivus fails to get European backing for obesity treatment Qsiva

EMA raises concerns about drug’s cardiovascular safety

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links